1. Home
  2. BAFN vs COEP Comparison

BAFN vs COEP Comparison

Compare BAFN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$5.82

Market Cap

30.9M

Sector

Finance

ML Signal

N/A

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

N/A

Current Price

$12.21

Market Cap

72.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAFN
COEP
Founded
1999
2017
Country
United States
United States
Employees
N/A
7
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
72.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BAFN
COEP
Price
$5.82
$12.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
30.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.34%
N/A
EPS Growth
133.93
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.55
$6.32
52 Week High
$19.00
$21.41

Technical Indicators

Market Signals
Indicator
BAFN
COEP
Relative Strength Index (RSI) 33.77 48.81
Support Level N/A $10.83
Resistance Level $8.26 $13.12
Average True Range (ATR) 0.33 0.83
MACD -0.11 0.16
Stochastic Oscillator 14.21 52.61

Price Performance

Historical Comparison
BAFN
COEP

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: